Ms Jahnavi Grover
Blacktown Hospital, Sydney (Australia)
Longer-term impact of PCSK9 inhibitors on major adverse cardiovascular events and all-cause mortality: a systematic review and meta-analysis of randomised controlled trials
Event: ESC Congress 2023
Topic: Lipid-Lowering Agents
Session: PCSK9 inhibitors and inclisiran
